These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1386277

  • 1. Role of 5-hydroxytryptamine receptors on luteinizing-hormone-releasing hormone release in the ovariectomized, estradiol-treated rat.
    Meyer DC, McRee C, Jacobs M.
    Brain Res Bull; 1992 Jun; 28(6):853-60. PubMed ID: 1386277
    [Abstract] [Full Text] [Related]

  • 2. Serotonin stimulation of the period of in vitro LHRH release is estradiol dependent.
    Meyer DC.
    Brain Res Bull; 1989 Mar; 22(3):525-30. PubMed ID: 2653571
    [Abstract] [Full Text] [Related]

  • 3. In-vitro pulsatile luteinizing hormone-releasing hormone output is dependent on hypothalamic region and the stage of the estrous cycle.
    Meyer DC.
    Biol Reprod; 1987 Dec; 37(5):1207-14. PubMed ID: 3327540
    [Abstract] [Full Text] [Related]

  • 4. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 5. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 06; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback.
    Advis JP, McCann SM, Negro-Vilar A.
    Endocrinology; 1980 Oct 06; 107(4):892-901. PubMed ID: 6997020
    [Abstract] [Full Text] [Related]

  • 8. In vitro luteinizing hormone-releasing hormone release from superfused rat hypothalami: site of action of progesterone and effect of estrogen priming.
    Kim K, Ramirez VD.
    Endocrinology; 1985 Jan 06; 116(1):252-8. PubMed ID: 3917249
    [Abstract] [Full Text] [Related]

  • 9. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA, Martin KF.
    Br J Pharmacol; 1986 Oct 06; 89(2):277-86. PubMed ID: 2430656
    [Abstract] [Full Text] [Related]

  • 10. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA, Dean RR, Edgar DM, Heller HC, Miller JD.
    J Biol Rhythms; 1993 Oct 06; 8(1):1-16. PubMed ID: 8490207
    [Abstract] [Full Text] [Related]

  • 11. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: modulation by ovarian hormones.
    Crowley WR, Kalra SP.
    Neuroendocrinology; 1987 Aug 26; 46(2):97-103. PubMed ID: 3306435
    [Abstract] [Full Text] [Related]

  • 13. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G, Barzizza A, Folghera S, Raiteri M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar 26; 343(3):229-36. PubMed ID: 1830929
    [Abstract] [Full Text] [Related]

  • 14. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 26; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 15. In vitro gonadotropin-releasing hormone release from hypothalamic tissues of ovariectomized estrogen-treated cynomolgus macaques.
    Levine JE, Bethea CL, Spies HG.
    Endocrinology; 1985 Jan 26; 116(1):431-8. PubMed ID: 3880545
    [Abstract] [Full Text] [Related]

  • 16. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
    Maura G, Roccatagliata E, Ulivi M, Raiteri M.
    Eur J Pharmacol; 1988 Jan 05; 145(1):31-8. PubMed ID: 2965025
    [Abstract] [Full Text] [Related]

  • 17. 5-HT receptor-mediated regulation of thyrotropin-releasing hormone release in rat spinal cord.
    Ono H, Ono SS, Fukuda H.
    Eur J Pharmacol; 1991 Oct 15; 203(2):283-5. PubMed ID: 1839283
    [Abstract] [Full Text] [Related]

  • 18. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec 15; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 19. GABA control of LHRH release is dependent on the steroid milieu.
    McRee RC, Meyer DC.
    Neurosci Lett; 1993 Jul 23; 157(2):227-30. PubMed ID: 8233058
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E.
    Pharmacol Biochem Behav; 1989 Jun 23; 33(2):329-34. PubMed ID: 2530590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.